Saturated fat, carbohydrate, and cardiovascular disease
- PMID: 20089734
- PMCID: PMC2824150
- DOI: 10.3945/ajcn.2008.26285
Saturated fat, carbohydrate, and cardiovascular disease
Abstract
A focus of dietary recommendations for cardiovascular disease (CVD) prevention and treatment has been a reduction in saturated fat intake, primarily as a means of lowering LDL-cholesterol concentrations. However, the evidence that supports a reduction in saturated fat intake must be evaluated in the context of replacement by other macronutrients. Clinical trials that replaced saturated fat with polyunsaturated fat have generally shown a reduction in CVD events, although several studies showed no effects. An independent association of saturated fat intake with CVD risk has not been consistently shown in prospective epidemiologic studies, although some have provided evidence of an increased risk in young individuals and in women. Replacement of saturated fat by polyunsaturated or monounsaturated fat lowers both LDL and HDL cholesterol. However, replacement with a higher carbohydrate intake, particularly refined carbohydrate, can exacerbate the atherogenic dyslipidemia associated with insulin resistance and obesity that includes increased triglycerides, small LDL particles, and reduced HDL cholesterol. In summary, although substitution of dietary polyunsaturated fat for saturated fat has been shown to lower CVD risk, there are few epidemiologic or clinical trial data to support a benefit of replacing saturated fat with carbohydrate. Furthermore, particularly given the differential effects of dietary saturated fats and carbohydrates on concentrations of larger and smaller LDL particles, respectively, dietary efforts to improve the increasing burden of CVD risk associated with atherogenic dyslipidemia should primarily emphasize the limitation of refined carbohydrate intakes and a reduction in excess adiposity.
Figures

Comment in
-
Diet-heart: a problematic revisit.Am J Clin Nutr. 2010 Mar;91(3):497-9. doi: 10.3945/ajcn.2010.29216. Epub 2010 Feb 3. Am J Clin Nutr. 2010. PMID: 20130097 No abstract available.
Similar articles
-
Reduction in saturated fat intake for cardiovascular disease.Cochrane Database Syst Rev. 2020 May 19;5(5):CD011737. doi: 10.1002/14651858.CD011737.pub2. Cochrane Database Syst Rev. 2020. Update in: Cochrane Database Syst Rev. 2020 Aug 21;8:CD011737. doi: 10.1002/14651858.CD011737.pub3. PMID: 32428300 Free PMC article. Updated.
-
Reduction in saturated fat intake for cardiovascular disease.Cochrane Database Syst Rev. 2020 Aug 21;8(8):CD011737. doi: 10.1002/14651858.CD011737.pub3. Cochrane Database Syst Rev. 2020. PMID: 32827219 Free PMC article.
-
Randomized clinical trials on the effects of dietary fat and carbohydrate on plasma lipoproteins and cardiovascular disease.Am J Med. 2002 Dec 30;113 Suppl 9B:13S-24S. doi: 10.1016/s0002-9343(01)00987-1. Am J Med. 2002. PMID: 12566134 Review.
-
Association of dietary nutrients with blood lipids and blood pressure in 18 countries: a cross-sectional analysis from the PURE study.Lancet Diabetes Endocrinol. 2017 Oct;5(10):774-787. doi: 10.1016/S2213-8587(17)30283-8. Epub 2017 Aug 29. Lancet Diabetes Endocrinol. 2017. PMID: 28864143
-
Changes in blood lipid concentrations associated with changes in intake of dietary saturated fat in the context of a healthy low-carbohydrate weight-loss diet: a secondary analysis of the Diet Intervention Examining The Factors Interacting with Treatment Success (DIETFITS) trial.Am J Clin Nutr. 2019 Feb 1;109(2):433-441. doi: 10.1093/ajcn/nqy305. Am J Clin Nutr. 2019. PMID: 30649213 Free PMC article. Clinical Trial.
Cited by
-
Novel soybean oils differing in fatty acid composition alter immune functions of moderately hypercholesterolemic older adults.J Nutr. 2012 Dec;142(12):2182-7. doi: 10.3945/jn.112.164335. Epub 2012 Oct 24. J Nutr. 2012. PMID: 23096013 Free PMC article. Clinical Trial.
-
Healthy Effects of Milk and Dairy Product Consumption in the Mediterranean Area and Japan.Endocr Metab Immune Disord Drug Targets. 2024;24(15):1813-1822. doi: 10.2174/0118715303289711240703080701. Endocr Metab Immune Disord Drug Targets. 2024. PMID: 38994611 Review.
-
Comparative Evaluation of a Low-Carbohydrate Diet and a Mediterranean Diet in Overweight/Obese Patients with Type 2 Diabetes Mellitus: A 16-Week Intervention Study.Nutrients. 2023 Dec 27;16(1):95. doi: 10.3390/nu16010095. Nutrients. 2023. PMID: 38201924 Free PMC article.
-
Palmitic acid methyl ester is a novel neuroprotective agent against cardiac arrest.Prostaglandins Leukot Essent Fatty Acids. 2019 Aug;147:6-14. doi: 10.1016/j.plefa.2018.11.011. Epub 2018 Nov 23. Prostaglandins Leukot Essent Fatty Acids. 2019. PMID: 30514597 Free PMC article.
-
Low-Fat Dietary Pattern among Postmenopausal Women Influences Long-Term Cancer, Cardiovascular Disease, and Diabetes Outcomes.J Nutr. 2019 Sep 1;149(9):1565-1574. doi: 10.1093/jn/nxz107. J Nutr. 2019. PMID: 31175807 Free PMC article. Clinical Trial.
References
-
- US Department of Health and Human Services Dietary guidelines for Americans 2005. Washington, DC: USDA, 2005
-
- Dayton S, Pearce M, Hashimoto S, et al. A controlled clinical trial of a diet high in unsaturated fat in preventing complications of atherosclerosis. Circulation 1969;40(suppl II):II-1–63
-
- Leren P. The Oslo Diet-Heart Study: eleven-year report. Circulation 1970;42:935–42 - PubMed
-
- Turpeinen O, Karvonen MJ, Pekkarinen M, Miettinen M, Elosuo R, Paavilainen E. Dietary prevention of coronary heart disease: the Finnish Mental Hospital Study. Int J Epidemiol 1979;8:99–118 - PubMed
-
- Lichtenstein AH, Appel LJ, Brands M, et al. Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation 2006;114:82–96 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical